WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Autoneuron
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, June 20, 2007, 27(25):6633-6646; doi:10.1523/JNEUROSCI.1091-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taoufik, E.
Right arrow Articles by Probert, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taoufik, E.
Right arrow Articles by Probert, L.

 Previous Article  |  Next Article 

Development/Plasticity/Repair
FLIPL Protects Neurons against In Vivo Ischemia and In Vitro Glucose Deprivation-Induced Cell Death

Era Taoufik,1 Samuel Valable,2 * Georg J. Müller,3 * Michael L. Roberts,4 * Didier Divoux,2 Antoine Tinel,5 Anda Voulgari-Kokota,1 Vivian Tseveleki,1 Fiorella Altruda,6 Hans Lassmann,3 Edwige Petit,2 and Lesley Probert1

1Laboratory of Molecular Genetics, Hellenic Pasteur Institute, 11521 Athens, Greece, 2Universite de Caen, Unité Mixte de Recherche, Centre National de la Recherche Scientifique 6185, 14074 Caen, France, 3Division of Neuroimmunology, Brain Research Institute, A-1090 Vienna, Austria, 4Regulon, 17455 Athens, Greece, 5Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland, and 6Dipartimento di Genetica, Biologia e Biochimica, Universita di Torino, 10126 Torino, Italy

Correspondence should be addressed to Lesley Probert, Laboratory of Molecular Genetics, Hellenic Pasteur Institute, 127 Vassilissis Sofias Avenue, 11521 Athens, Greece. Email: lesley_probert{at}hol.gr

Knowledge of the molecular mechanisms that underlie neuron death after stroke is important to allow the development of effective neuroprotective strategies. In this study, we investigated the contribution of death receptor signaling pathways to neuronal death after ischemia using in vitro and in vivo models of ischemic injury and transgenic mice that are deficient in tumor necrosis factor receptor I (TNFRI KO) or show neuron-specific overexpression of the long isoform of cellular Fas-associated death domain-like interleukin-1-ß-converting enzyme-inhibitory protein (FLIPL). Caspase 8 was activated in brain lesions after permanent middle cerebral artery occlusion (pMCAO) and in cortical neurons subjected to glucose deprivation (GD) and was necessary for GD-induced neuron death. Thus, neurons treated with zIETD-FMK peptide or overexpressing a dominant-negative caspase 8 mutant were fully protected against GD-induced death. The presence of the neuroprotective TNFRI was necessary for selectively sustaining p50/p65NF-{kappa}B activity and the expression of the p43 cleavage form of FLIPL, FLIP(p43), an endogenous inhibitor of caspase 8, in pMCAO lesions and GD-treated neurons. Moreover, TNF pretreatment further upregulated p50/p65NF-{kappa}B activity and FLIP(p43) expression in neurons after GD. The knock-down of FLIP in wild-type (WT) neurons using a short hairpin RNA revealed that FLIPL is essential for TNF/TNFRI-mediated neuroprotection after GD. Furthermore, the overexpression of FLIPL was sufficient to rescue TNFRI KO neurons from GD-induced death and to enhance TNF neuroprotection in WT neurons, and neuron-specific expression of FLIPL in transgenic mice significantly reduced lesion volume after pMCAO. Our results identify a novel role for the TNFRI–NF-{kappa}B–FLIPL pathway in neuroprotection after ischemia and identify potential new targets for stroke therapy.

Key words: ischemia; neuroprotection; apoptosis; TNF receptor I; caspase 8; FLIP


Received Oct. 4, 2006; revised April 17, 2007; accepted May 3, 2007.

Correspondence should be addressed to Lesley Probert, Laboratory of Molecular Genetics, Hellenic Pasteur Institute, 127 Vassilissis Sofias Avenue, 11521 Athens, Greece. Email: lesley_probert{at}hol.gr




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Taoufik, E. Petit, D. Divoux, V. Tseveleki, M. Mengozzi, M. L. Roberts, S. Valable, P. Ghezzi, J. Quackenbush, M. Brines, et al.
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury
PNAS, April 22, 2008; 105(16): 6185 - 6190.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-